Your browser doesn't support javascript.
loading
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.
Amini, Shahideh; Rezabakhsh, Aysa; Hashemi, Javad; Saghafi, Fatemeh; Azizi, Hossein; Sureda, Antoni; Habtemariam, Solomon; Khayat Kashani, Hamid Reza; Hesari, Zahra; Sahebnasagh, Adeleh.
Afiliação
  • Amini S; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Rezabakhsh A; Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hashemi J; Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
  • Saghafi F; Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Azizi H; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sureda A; Research Group On Community Nutrition and Oxidative Stress, University of the Balearic Islands, Palma, Spain.
  • Habtemariam S; CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038), Instituto de Salud Carlos III, Madrid, Spain.
  • Khayat Kashani HR; Pharmacognosy Research Laboratories and Herbal Analysis Services, University of Greenwich, Central Avenue, Chatham-Maritime, Kent, ME4 4TB, UK.
  • Hesari Z; Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sahebnasagh A; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
J Intensive Care ; 10(1): 38, 2022 Jul 30.
Article em En | MEDLINE | ID: mdl-35908022

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article